Phosphatidylcholine and Phosphatidylserine Uniquely Modify the Secondary Structure of α-Synuclein Oligomers Formed in Their Presence at the Early Stages of Protein Aggregation.
AFM-IR
oligomers
phosphatidylcholine and phosphatidylserine
protein secondary structure
protein−lipid interaction
α-Synuclein aggregation
Journal
ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337
Informations de publication
Date de publication:
17 08 2022
17 08 2022
Historique:
pubmed:
30
7
2022
medline:
19
8
2022
entrez:
29
7
2022
Statut:
ppublish
Résumé
Abrupt aggregation of α-synuclein (α-Syn) leads to a formation of highly toxic protein oligomers. These aggregates are the underlying molecular cause of an onset of the irreversible degeneration of dopaminergic neurons in midbrain, hypothalamus, and thalamus, a pathology known as Parkinson's disease. The transient nature of oligomers, as well as their structural and morphological heterogeneity, limits the use of cryo-electron microscopy and solid-state NMR, classical tools of structural biology, for elucidation of their secondary structure. Despite this limitation, numerous pieces of experimental evidence suggest that phospholipids can uniquely alter the structure and toxicity of oligomers. In this study, we utilize an innovative nano-infrared imaging technique, also known as atomic force microscopy infrared (AFM-IR) spectroscopy, to examine the structure of individual α-Syn oligomers grown in the presence of phosphatidylcholine (α-Syn:PC) and phosphatidylserine (α-Syn:PS). We determined the amount of the parallel and the antiparallel β-sheets, as well as the amount the α-helix and the unordered protein, in the secondary structure of α-Syn:PC and α-Syn:PS formed at day 2 (D2), 8 (D8), and 15 (D15) after initiation of protein aggregation. We found a gradual decrease in the amount of the parallel β-sheet in both α-Syn:PC and α-Syn:PS from D2 to D15 together with an increase in the α-helix and the unordered protein secondary structure. We infer that this is due to the presence of lipids in the structure of oligomers that prevent an expansion of the parallel β-sheet upon interaction of the oligomers with monomeric α-Syn.
Identifiants
pubmed: 35904551
doi: 10.1021/acschemneuro.2c00355
pmc: PMC10405296
mid: NIHMS1921590
doi:
Substances chimiques
Phosphatidylcholines
0
Phosphatidylserines
0
Protein Aggregates
0
alpha-Synuclein
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2380-2385Subventions
Organisme : NIGMS NIH HHS
ID : R35 GM142869
Pays : United States
Références
Biochemistry. 2010 Feb 9;49(5):862-71
pubmed: 20041693
J Am Chem Soc. 2013 Feb 27;135(8):2943-6
pubmed: 23398174
Protein Pept Lett. 2011 Mar;18(3):230-40
pubmed: 20858207
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7831-7836
pubmed: 32213585
Biochem Biophys Res Commun. 2007 May 11;356(3):548-53
pubmed: 17374364
Nat Struct Mol Biol. 2016 May;23(5):409-15
pubmed: 27018801
Cell. 2012 May 25;149(5):1048-59
pubmed: 22632969
Neuron. 2003 Feb 20;37(4):583-95
pubmed: 12597857
Chembiochem. 2020 Feb 17;21(4):481-485
pubmed: 31299124
J Mol Biol. 2006 Jan 6;355(1):63-71
pubmed: 16303137
Free Radic Biol Med. 2011 Feb 1;50(3):428-37
pubmed: 21130160
Biophys J. 2014 Jan 7;106(1):263-71
pubmed: 24411258
Commun Biol. 2018 May 3;1:44
pubmed: 30271927
ACS Nano. 2020 May 26;14(5):5213-5222
pubmed: 32159944
Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):E1994-2003
pubmed: 25855634
J Phys Chem Lett. 2022 Mar 17;13(10):2467-2473
pubmed: 35266717
Elife. 2018 Jul 03;7:
pubmed: 29969391
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7230-7235
pubmed: 29941606
Anal Chem. 2020 May 19;92(10):6806-6810
pubmed: 32347706
Anal Chem. 2020 Aug 18;92(16):11297-11304
pubmed: 32683857
Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):7065-70
pubmed: 27298346
ACS Nano. 2018 Jul 24;12(7):6612-6619
pubmed: 29932670
Sci Rep. 2016 Aug 08;6:31155
pubmed: 27499269
J Neurosci. 2007 Aug 22;27(34):9220-32
pubmed: 17715357
Front Cell Neurosci. 2019 May 01;13:175
pubmed: 31118888
Nat Commun. 2015 Jul 28;6:7831
pubmed: 26215704
Neurobiol Dis. 2015 Jul;79:150-63
pubmed: 25931201
Sci Rep. 2016 Apr 14;6:24526
pubmed: 27075649
Nat Commun. 2018 Sep 6;9(1):3609
pubmed: 30190461
Anal Chem. 2019 Feb 5;91(3):2472-2479
pubmed: 30624904
J Parkinsons Dis. 2017;7(3):433-450
pubmed: 28671142
Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96
pubmed: 24854788
J Phys Chem Lett. 2021 May 13;12(18):4407-4414
pubmed: 33945282
J Parkinsons Dis. 2018;8(s1):S3-S8
pubmed: 30584159
Analyst. 2015 Aug 7;140(15):4967-80
pubmed: 26042229
Biochim Biophys Acta. 2012 Feb;1818(2):162-71
pubmed: 21819966
ACS Nano. 2017 Dec 26;11(12):12202-12209
pubmed: 29165985
Biochim Biophys Acta Proteins Proteom. 2019 May;1867(5):483-491
pubmed: 30287222
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15871-6
pubmed: 16247008
Nat Chem Biol. 2015 Mar;11(3):229-34
pubmed: 25643172
Nat Commun. 2020 Jun 10;11(1):2945
pubmed: 32522983
J Mol Biol. 2009 Jul 24;390(4):775-90
pubmed: 19481095